Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide

AUTOR(ES)

Castro, Renata Rodrigues Teixeira de, Serra, Salvador Manoel, Nóbrega, Antonio Claudio Lucas da

FONTE

Arquivos Brasileiros de Cardiologia

DATA DE PUBLICAÇÃO

2000-09

RESUMO

OBJECTIVE: Parasympathetic dysfunction is an independent risk factor in individuals with coronary artery disease, and cholinergic stimulation is a potential therapeutical option. We determined the effects of pyridostigmine bromide, a reversible anticholinesterase agent, on electrocardiographic variables of healthy individuals. METHODS: We carried out a cross-sectional, double blind, randomized, placebo-controlled study. We obtained electrocardiographic tracings in 12 simultaneous leads of 10 healthy young individuals at rest before and after oral administration of 45 mg of pyridostigmine or placebo. RESULTS: Pyridostigmine increased RR intervals (before: 886±27 ms vs after: 1054±37 ms) and decreased QTc dispersion (before: 72±9ms vs after: 45±3ms), without changing other electrocardiographic variables (PR segment, QT interval, QTc, and QT dispersion). CONCLUSION: Bradycardia and the reduction in QTc dispersion induced by pyridostigmine may effectively represent a protective mechanism if these results can be reproduced in individuals with cardiovascular diseases.

Documentos Relacionados

• Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease
• QT dispersion.
• Pigmentary dispersion.
• New Generation Antipsychotic Drugs and QTc Interval Prolongation
• QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study